7 Critical Medication Questions for Adults Over 65
Essential pharmacist consultations to manage polypharmacy risks in seniors
1Polypharmacy risks in aging
After 65, adults typically manage multiple prescriptions alongside OTC drugs and supplements, creating complex interaction risks. The National Institute on Aging highlights how aging alters drug metabolism while multiple medications increase side effect potential. Pharmacists become crucial allies when patients bring complete medication lists, including non-prescription items often omitted from digital records.
2Hidden ingredient duplication
Many seniors unknowingly double-dose active ingredients through combination products like pain relievers and cold medicines. The NIA warns about acetaminophen overlap in different medications. Pharmacists can cross-check all products when patients bring physical labels or photos, preventing accidental overdoses that home label reading might miss due to small print or confusing terminology.
3Side effects masquerading as aging
Common symptoms like dizziness or memory issues may stem from medications rather than natural aging. The FDA advises tracking symptom onset relative to new prescriptions or dosage changes. Pharmacists help determine when to consult prescribers about adjustments, as abrupt self-discontinuation of certain drugs can cause withdrawal effects or condition flare-ups.
4Timing and administration complexities
Juggling multiple medications requires precise scheduling around meals and other drugs. FDA guidelines emphasize asking pharmacists about food interactions, optimal timing, and missed dose protocols. For seniors struggling with complex regimens, pharmacists can recommend organizational tools or suggest prescriber consultations about simplification opportunities.
5Medication necessity reviews
The NIA promotes 'deprescribing' - systematically evaluating whether older medications remain necessary. Pharmacists help identify candidates for discussion with prescribers, especially when multiple specialists prescribe separately. This differs from self-discontinuation, focusing instead on making each medication purposeful rather than arbitrarily reducing quantities.
6Cost-saving strategies
With Medicare Part D out-of-pocket caps coming in 2026, pharmacists can identify generics, alternative formulations, or different fulfillment options to reduce expenses. The FDA specifically recommends asking about lower-cost alternatives before resorting to dangerous practices like dose-skipping. Some Medicare plans offer Medication Therapy Management programs for comprehensive cost/benefit analyses.
7Comprehensive medication reviews
Medicare requires plans to offer Medication Therapy Management for qualifying beneficiaries, providing full medication assessments at no cost. Even without qualification, pharmacists can perform basic reviews to identify interaction risks or unnecessary medications. These go beyond single-prescription consultations to evaluate the entire medication ecosystem.
8Documentation as prevention
The FDA recommends maintaining current medication lists including dosages and purposes, shared with all healthcare providers. This becomes critical during emergencies or specialist visits where full medication histories might otherwise be missed. Digital or paper lists should accompany patients to every medical appointment and pharmacy visit.
Original article: SavingAdvice.com Blog — 7 Critical Medication Questions for Adults Over 65